Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,598.00INR
3:29pm IST
Change (% chg)

Rs-34.50 (-1.31%)
Prev Close
Rs2,632.50
Open
Rs2,640.00
Day's High
Rs2,644.65
Day's Low
Rs2,580.45
Volume
480,026
Avg. Vol
676,817
52-wk High
Rs2,964.00
52-wk Low
Rs1,872.95

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Laboratories Launches Ramelteon Tablets In U.S. Market
3:09pm IST 

July 23 (Reuters) - Dr.Reddy's Laboratories Ltd ::LAUNCHES RAMELTEON TABLETS, IN U.S. MARKET.  Full Article

FDA Approves First Generics Of Lyrica
Monday, 22 Jul 2019 

July 22 (Reuters) - U.S. Food and Drug Administration::FDA APPROVES FIRST GENERICS OF LYRICA.U.S. FOOD AND DRUG ADMINISTRATION SAYS ON JULY 19, FDA APPROVED MULTIPLE APPLICATIONS FOR FIRST GENERICS OF LYRICA (PREGABALIN).U.S. FDA SAYS GRANTED APPROVALS FOR GENERIC VERSIONS OF LYRICA TO ALKEM LABORATORIES, DR. REDDY'S LABORATORIES, INVAGEN PHARMACEUTICALS.U.S. FDA SAYS ALSO GRANTED APPROVALS FOR GENERIC VERSIONS OF LYRICA TO MSN LABORATORIES LTD, SCIEGEN PHARMACEUTICALS INC, AND TEVA PHARMACEUTICALS.  Full Article

Indivior Announces Court Of Appeals Ruling On Indivior Patents
Monday, 15 Jul 2019 

July 15 (Reuters) - Indivior PLC ::COURT OF APPEALS RULES ON INDIVIOR PATENTS.WATSON/ACTAVIS REMAINS ENJOINED FROM LAUNCHING THEIR GENERIC BUPRENORPHINE/NALOXONE SUBLINGUAL FILM PRODUCT UNTIL EXPIRATION OF '514 PATENT.  Full Article

Dr.Reddy's Labs Launches Over-the-counter Mucinex D Tablets In U.S.
Tuesday, 9 Jul 2019 

July 9 (Reuters) - Dr.Reddy's Laboratories Ltd ::LAUNCHES OVER-THECOUNTER STORE BRAND EQUIVALENT OF MUCINEX D EXTENDED RELEASE TABLETS IN THE U.S. MARKET.  Full Article

Dr.Reddy's Laboratories Launches Carboprost Tromethamine Injection USP In U.S.
Wednesday, 3 Jul 2019 

July 3 (Reuters) - Dr.Reddy's Laboratories Ltd ::LAUNCHES CARBOPROST TROMETHAMINE INJECTION USP, 250 MCG/ML (1ML) SINGLE-DOSE VIAL IN U.S..  Full Article

Dr.Reddy's Laboratories To Sell Neurology Branded Products To Upsher-Smith Laboratories, LLC
Friday, 14 Jun 2019 

June 14 (Reuters) - Dr.Reddy's Laboratories Ltd ::ENTERS DEFINITIVE AGREEMENT TO SELL ITS NEUROLOGY BRANDED PRODUCTS TO UPSHER-SMITH LABORATORIES, LLC.CO TO GET UPFRONT CONSIDERATION OF $70 MILLION, $40.5 MILLION IN NEAR TERM MILESTONES, ADDITIONAL FINANCIAL CONSIDERATIONS.DR. REDDY'S WILL RECEIVE SALES BASED ROYALTIES ON A QUARTERLY BASIS.  Full Article

Dr.Reddy's Laboratories Announces Re-Launch Of Zenatane In U.S. Market
Monday, 3 Jun 2019 

June 3 (Reuters) - Dr.Reddy's Laboratories Ltd ::ANNOUNCES RE-LAUNCH OF ZENATANE (ISOTRETINOIN CAPSULES, USP) IN U.S. MARKET.  Full Article

India's Dr.Reddy's Laboratories March-Qtr Net PAT Rises
Friday, 17 May 2019 

May 17 (Reuters) - Dr.Reddy's Laboratories Ltd ::MARCH QUARTER CONSOL NET PROFIT AFTER TAX 4.55 BILLION RUPEES VERSUS PROFIT OF 2.72 BILLION RUPEES LAST YEAR.CONSENSUS FORECAST FOR MARCH QUARTER CONSOL PROFIT WAS 4.24 BILLION RUPEES.MARCH QUARTER CONSOL NET SALES 37.47 BILLION RUPEES VERSUS 34.46 BILLION RUPEES LAST YEAR.RECOMMENDED DIVIDEND OF 20 RUPEES PER SHARE.  Full Article

Dr.Reddy's Laboratories Says USFDA Classified Inspection At Srikakulam Plant As Voluntary Action Initiated
Friday, 19 Apr 2019 

April 19 (Reuters) - Dr.Reddy's Laboratories Ltd ::GOT COMMUNICATION FROM US FDA THAT INSPECTION AT SRIKAKULAM PLANT CLASSIFIED AS VOLUNTARY ACTION INITIATED.  Full Article

Dr.Reddy's Laboratories Gets EIR From USFDA For Plant At Bachupally, Hyderabad
Monday, 15 Apr 2019 

April 15 (Reuters) - Dr.Reddy's Laboratories Ltd ::DR.REDDY'S LABORATORIES LTD SAYS GOT ESTABLISHMENT INSPECTION REPORT FROM USFDA FOR FORMULATIONS MANUFACTURING PLANT - 3 AT BACHUPALLY, HYDERABAD.  Full Article

BUZZ-India's Dr.Reddy's gains most in nearly 13 weeks after U.S FDA report

** Shares of Indian drugmaker Dr.Reddy's Laboratories Ltd climbs as much as 4.9 pct to 2,689.65 rupees, in their biggest intraday pct gain since Nov. 11